Review

Endocrinopathies from checkpoint inhibitors: Incidence, outcomes, and management

Randol Kennedy, MD, FACP, Hussein Awada, MD, Naga Vura, MD, Daniela Ciltea, MD and Michael Morocco, MD
Cleveland Clinic Journal of Medicine May 2023, 90 (5) 307-317; DOI: https://doi.org/10.3949/ccjm.90a.22032

Article Information

vol. 90 no. 5 307-317
DOI 
https://doi.org/10.3949/ccjm.90a.22032
PubMed 
37127339
Published By 
Cleveland Clinic Journal of Medicine
Print ISSN 
0891-1150
Online ISSN 
1939-2869
History 
  • Published online May 1, 2023.
Copyright & Usage 
Copyright © 2023 The Cleveland Clinic Foundation. All Rights Reserved.

Author Information

  1. Randol Kennedy, MD, FACP⇑
  1. Department of Internal Medicine, Cleveland Clinic Akron General Hospital, Akron, OH
  1. Address:
    Randol Kennedy, MD, FACP, Department of Internal Medicine, Cleveland Clinic Akron General Hospital, 1 Akron General Avenue, Akron, OH 44307; kennedr{at}ccf.org
  1. Hussein Awada, MD
  1. Department of Internal Medicine, Cleveland Clinic Akron General Hospital, Akron, OH
  1. Naga Vura, MD
  1. Department of Internal Medicine, Cleveland Clinic Akron General Hospital, Akron, OH
  1. Daniela Ciltea, MD
  1. Department of Endocrinology, Diabetes and Metabolism, Cleveland Clinic Akron General Hospital, Akron, OH
  1. Michael Morocco, MD
  1. Department of Endocrinology, Diabetes and Metabolism, Cleveland Clinic Akron General Hospital, Akron, OH

Cited By...

Back to top

In this issue

Print
Download PDF
Article Alerts
Email Article
Citation Tools

Jump to section

Subjects